• Return to Headlines

Puma Biotechnolo Has Returned 23.1% Since SmarTrend Recommendation (PBYI)

By James Quinn

SmarTrend identified a Downtrend for Puma Biotechnolo (NASDAQ:PBYI) on March 27th, 2018 at $67.73. In approximately 3 months, Puma Biotechnolo has returned 23.07% as of today's recent price of $52.10.

In the past 52 weeks, Puma Biotechnolo share prices have been bracketed by a low of $47.00 and a high of $136.90 and are now at $52.10, 11% above that low price. The 200-day and 50-day moving averages have moved 0.56% lower and 1.66% lower over the past week, respectively.

Puma Biotechnology, Inc. is a development-stage biopharmaceutical company. The Company develops novel therapeutics for the treatment of various forms of cancer. Puma focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Puma Biotechnolo.

Log in and add Puma Biotechnolo (PBYI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights puma biotechnolo

Ticker(s): PBYI